IP Library Granted Patent US 8,030,043
Granted Patent B2
US 8,030,043 · App. 11/918,328 · Granted Oct 4, 2011

β-galactoside-α2,3-sialyltransferase, a gene encoding thereof, and a method for producing thereof

Assignee: Japan Tobacco Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,030,043
App. No.
11/918,328
Granted
Oct 4, 2011
Kind
B2
Abstract

The present invention provides a novel β-galactoside-α2,3-sialyltransferase and a nucleic acid encoding the sialyltransferase. The present invention also provides a microorganism producing the sialyltransferase, as well as a method for producing the sialyltransferase using such a microorganism. The present invention further provides a vector carrying a nucleic acid encoding the sialyltransferase, and a host cell transformed with the vector, as well as a method for producing a recombinant β-galactoside-α2,3-sialyltransferase. The present invention further provides a method for preparing a sialylsugar chain, which uses the sialyltransferase of the present invention.

Claims (25)

1. An isolated protein comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 2, amino acid residues 22-409 of SEQ ID NO: 2, SEQ ID NO: 29, and amino acid residues 25-409 of SEQ ID NO: 29.

2. An isolated protein having β-galactoside-α2,3-sialyltransferase activity, which comprises an amino acid sequence comprising conservative substitution of one or more amino acids in, and sharing an amino acid homology of at least 90% or more with, an amino acid sequence selected from the group consisting of SEQ ID NO: 2, amino acid residues 22-409 of SEQ ID NO: 2, SEQ ID NO: 29, and amino acid residues 25-409 of SEQ ID NO: 29.

3. An isolated protein having β-galactoside-α2,3-sialyltransferase activity, which comprises an amino acid sequence sharing an amino acid homology of at least 90% or more with an amino acid sequence selected from the group consisting of SEQ ID NO: 2, amino acid residues 22-409 of SEQ ID NO: 2, SEQ ID NO: 29, and amino acid residues 25-409 of SEQ ID NO: 29.

4. An isolated protein having β-galactoside-α2,3-sialyltransferase activity, which is encoded by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, nucleotides 64-1230 of SEQ ID NO: 1, SEQ ID NO: 28, and nucleotides 73-1230 of SEQ ID NO: 28.

5. An isolated protein having β-galactoside-α2,3-sialyltransferase activity, which is encoded by a nucleic acid comprising a nucleotide sequence hybridizable under conditions including hybridization at 65° C. in 0.5M sodium phosphate pH 7.2, 1 mM EDTA, 7% SDS, 1% BSA, and washing at 65° C. in 40 mM sodium phosphate buffer pH 7.2, 1 mM EDTA, 5% SDS, 0.5% BSA and at 65° C. in 40 mM sodium phosphate buffer pH 7.2, 1 mM EDTA, 1% SDS with the full length complementary strand of a nucleotide sequence selected from the group consisting of SEQ ID NO: 1 and SEQ ID NO: 28.

6. The isolated protein according to claim 3 , which is obtained from a microorganism which belongs to Vibrionaceae.

7. An isolated nucleic acid encoding a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 2, amino acid residues 22-409 of SEQ ID NO: 2, SEQ ID NO: 29, and amino acid residues 25-409 of SEQ ID NO: 29.

8. An isolated nucleic acid encoding a protein having β-galactoside-α2,3-sialyltransferase activity, wherein the protein comprises an amino acid sequence comprising conservative substitution of one or more amino acids in, and sharing an amino acid homology of at least 90% or more with, an amino acid sequence selected from the group consisting of SEQ ID NO: 2, amino acid residues 22-409 of SEQ ID NO: 2, SEQ ID NO: 29, and amino acid residues 25-409 of SEQ ID NO: 29.

9. An isolated nucleic acid encoding a protein having β-galactoside-α2,3-sialyltransferase activity, wherein the protein comprises an amino acid sequence sharing a homology of at least 90% with an amino acid sequence selected from the group consisting of SEQ ID NO: 2, amino acid residues 22-409 of SEQ ID NO: 2, SEQ ID NO: 29, and amino acid residues 25-409 of SEQ ID NO: 29.

10. An isolated nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, nucleotides 64-1230 of SEQ ID NO: 1, SEQ ID NO: 28, and nucleotides 73-1230 of SEQ ID NO: 28.

11. An isolated nucleic acid encoding a protein having β-galactoside-α2,3-sialyltransferase activity, wherein the nucleic acid comprises a nucleotide sequence hybridizable under conditions including hybridization at 65° C. in 0.5M sodium phosphate pH 7.2, 1 mM EDTA, 7% SDS, 1% BSA, and washing at 65° C. in 40 mM sodium phosphate buffer pH 7.2, 1 mM EDTA, 5% SDS, 0.5% BSA and at 65° C. in 40 mM sodium phosphate buffer pH 7.2, 1 mM EDTA, 1% SDS, with the full length complementary strand of a nucleotide sequence selected from the group consisting of SEQ ID NO: 1 and SEQ ID NO: 28.

12. A recombinant vector comprising the nucleic acid according to claim 9 .

13. An isolated host cell transformed with the recombinant vector according to claim 12 .

14. An isolated microorganism of the Vibrionaceae, which expresses the protein according to claim 1 .

15. The microorganism according to claim 14 , which is Photobacterium phosphoreum strain JT-ISH-467 (Accession No. NITE BP-88), or Photobacterium sp. strain JT-ISH-224 (Accession No. NITE BP-87).

16. A method for producing a recombinant protein having β-galactoside-α2,3-sialyltransferase activity, which comprises the following steps:

1) transforming and isolating a host cell with a recombinant vector comprising the nucleic acid according to claim 7 ;

2) culturing the transformed host cell; and

3) isolating the protein having β-galactoside-α2,3-sialyltransferase activity from the cultured host cell or the culture supernatant.

17. A method for preparing a sialylated sugar chain, which comprises:

(i) preparing a solution containing the protein according to claim 1 , a glycosyl donor substrate and a glycosyl acceptor substrate;

(ii) causing sialic acid transfer reaction in the solution; and

(iii) obtaining the generated sialylated sugar chain from the reaction solution.

18. The isolated protein of claim 1 , which comprises SEQ ID NO: 2.

19. The method of claim 16 , wherein said nucleic acid encodes a protein comprising SEQ ID NO: 2.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2008
From: YAMAMOTO, TAKESHI; TSUKAMOTO, HIROSHI; TAKAKURA, YOSHIMITSU
To: JAPAN TOBACCO INC.
Reel/Frame 022020/0295 →
Priority Claims (2)
WO PCT/JP2005/007340 · Apr 15, 2005 · international
WO PCT/JP2005/010814 · Jun 13, 2005 · international
Continuity (1)
Related Publication 20100291631A1 · Nov 18, 2010